Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rotstein

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|February 26, 2010
Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 - 2008Hanbiao Yang, David M Rotstein
Bioorganic & Medicinal Chemistry Letters|July 21, 2010
Exploration of a new series of CCR5 antagonists: multi-dimensional optimization of a sub-series containing N-substituted pyrazolesRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle seriesJutta Wanner, Lijing Chen, Rémy C Lemoine, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maravirocRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2010
Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonistsRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
British Journal of Pharmacology|March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligandsDavid C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2010
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|February 26, 2010
Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 - 2008Hanbiao Yang, David M Rotstein
Bioorganic & Medicinal Chemistry Letters|July 21, 2010
Exploration of a new series of CCR5 antagonists: multi-dimensional optimization of a sub-series containing N-substituted pyrazolesRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle seriesJutta Wanner, Lijing Chen, Rémy C Lemoine, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maravirocRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2010
Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonistsRémy C Lemoine, Ann C Petersen, Lina Setti, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
Synthesis, SAR and evaluation of [1,4']-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Nicole Manser, et al.
British Journal of Pharmacology|March 18, 2014
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligandsDavid C Swinney, Paul Beavis, Kai-Ting Chuang, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2009
Spiropiperidine CCR5 antagonistsDavid M Rotstein, Stephen D Gabriel, Ferenc Makra, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2010
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonistsDavid M Rotstein, Chris R Melville, Fernando Padilla, et al.
Pageof 1